A new target for myeloma therapy
- PMID: 22323404
- DOI: 10.1182/blood-2011-12-394486
A new target for myeloma therapy
Abstract
In this issue of Blood, Azab and colleagues demonstrate that PSGL-1 expressed on myeloma cells is involved with regulating tumor cell extravasation, homing, disease progression, and drug resistance.
Comment on
-
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.Blood. 2012 Feb 9;119(6):1468-78. doi: 10.1182/blood-2011-07-368050. Epub 2011 Nov 16. Blood. 2012. PMID: 22096244 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources

